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AbstrAct
The aim of  this study is to examine the dynamics in the relationship 
between the Legislative and the Judiciary in the implementation of  the fun-
damental right to healthcare in Brazil, based on a documental and bibliogra-
phical analysis of  lawsuits aimed at obtaining drugs not incorporated by the 
Unified Health System. The enshrinement by the Brazilian Constitution of  
1988 of  the right to healthcare as a duty of  the State and a right of  all, led to 
the modification of  the performance of  judges. From the position of  self-
-restraint of  the Judiciary on the subject, there was a growing intervention in 
public policies related to health. The Judiciary itself, from the Federal Supre-
me Court (public hearing) and the National Council of  Justice (recommen-
dations and resolutions), began to dictate guidelines aimed at rationalizing 
the performance of  the judges. Nonetheless, the Legislative also triggered a 
reaction to the advancements of  the Judiciary, through the editing of  Law 
12.401/2011 and the emphasis on the consensual solutions enshrined in 
the Code of  Civil Proceedings of  2015 and Law 13.140/2015. Recent de-
cisions issued by the Superior Court of  Justice and the Federal Supreme 
Court point to the inflection in the position of  the Judiciary. In this sense, 
it is necessary to emphasize the importance of  recognizing the institutional 
limits for the actions of  the Judiciary in the control of  public policies related 
to health as well as the establishment of  institutional dialogue between the 
Judiciary and the Administration to overcome mutual misunderstandings 
and incomprehension.
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resumo
Por meio deste estudo, pretende-se examinar a dinâmica na relação entre Poder Legislativo e Poder 
Judiciário na implementação do direito fundamental à saúde no Brasil, a partir de uma análise documental 
das ações judiciais que objetivam obter medicamentos não incorporados pelo Sistema Único de Saúde. A 
consagração, pela Constituição brasileira de 1988, do direito à saúde como dever do Estado e direito de to-
dos, levou à modificação da atuação dos juízes no tocante a ações que visam determinar o fornecimento de 
medicamentos. Da posição de autocontenção do Judiciário no tocante ao tema, passou-se à crescente inter-
venção nas políticas públicas relacionadas à saúde, com impactos no orçamento destinado a atuações nesse 
campo. O próprio Poder Judiciário, a partir do Supremo Tribunal Federal (audiência pública) e do Conselho 
Nacional de Justiça (recomendações e resoluções), começou a ditar diretrizes visando racionalizar a atuação 
dos juízes. Não obstante, o Poder Legislativo também desencadeou uma reação ao avanço do Judiciário, por 
meio da edição da Lei 12.401/2011 e da ênfase às soluções consensuais consagradas pelo Código de Pro-
cesso Civil de 2015 e pela Lei 13.140/2015. Recentes decisões do STJ e do STF apontam para a inflexão na 
posição do Judiciário, mais deferente em relação às disposições legislativas e, sobretudo, à atuação do Exe-
cutivo. Nesse sentido, necessário destacar a importância do reconhecimento dos limites institucionais para a 
atuação do Judiciário no controle das políticas públicas relacionadas à saúde e do estabelecimento de diálogo 
institucional entre Judiciário e Administração para superar desconfianças e incompreensões recíprocas.
Palavras-chave: Direito fundamental à saúde. Judicialização. Medicamentos. Relacionamento entre Legi-
slativo e Judiciário.
1. IntroductIon
The examination of  the so-called judicialization of  healthcare in Brazil, from the study of  the evolution 
of  judicial decisions concerning the delivery of  medicines, allows interesting considerations regarding the 
relationship between Judiciary and Legislative, as well as the limits to the creative activity of  the judge.
The right to healthcare, in spite of  its terminological imprecision, as to the object and extent, was enshri-
ned verbatim in arts. 6 and 196 of  the Brazilian Constitution of  1988, which, over time, gives rise to diffe-
rent positions on the part of  the subjects of  subjective right, and on the functions of  the State: executive, 
legislative and judicial.
At the outset, a more reticent position is identified regarding the granting of  requests for the delivery of  
medicines; in a second moment, due to the constitutional order of  immediate applicability of  the constitu-
tional precepts, the Judiciary, even through the action of  the Federal Supreme Court, will intervene more 
vehemently, and in this bias determines the systematic granting of  drugs, which generates greater impacts 
on the health budget in Brazil; the confrontation between the judiciary and the executive reveals itself  and 
the resulting judicialization of  politics. In the second decade of  the 21st century, we identify the phase of  
rationality seeking in judicial intervention, a situation in which the courts seem to be at present.
This quest for greater rationality seems to be a result of  factors of  two orders, internal to the Judicial 
Branch itself, and to the Federal Supreme Court’s actions, as well as external ones, materialized in the work 
of  the Legislative. Among the first ones, reference should be made to the holding of  a public hearing in 
2009, in which the need to establish parameters for the Supreme Court’s action in judicial actions involving 
the right to healthcare was discussed, as well as the work of  the National Council of  Justice, a Judiciary 
agency, chaired by the President of  the Federal Supreme Court, issuing recommendations and resolutions 
on the subject.
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On the other hand, the Legislative Branch has worked to establish criteria for the incorporation of  new 
technologies, among which are inserted the medicines (Law 12401/04/2011), which undoubtedly becomes 
a matter that judges should consider in their decisions, and also in the search for dialogued and consen-
sual solutions, which materialized mainly in the 2015 edition of  the Code of  Civil Proceedings and Law 
13.140/06/2015. As will be seen, such diplomas favor the search for mediation and conciliation, among 
other fields, regarding the right to healthcare. The Judiciary, on the other hand, in the search for alternative 
solutions to conflict resolution, also favored this second group of  measures.
To this end, this study initially deals with the right to healthcare, content and extent, and the evolution of  
judicial decisions regarding the granting of  medicines, based on the way the Judiciary has positioned itself. 
It then examines the way in which the Legislature has reacted and how excesses identified in the work of  
the Judiciary have been subject to containment by legal measures. Finally, it seeks to assess the prospects 
for change in case law and what measures may contribute to more appropriate decisions. The constitutional 
parameters are analyzed in the field of  the right to health, and if  this discussion reveals the existence of  
fields where the Judiciary should be more deferential towards legislative and administrative choices, above 
all because it does not detain technical expertise and because its exaggerated intervention has the power to 
systemically affect public health by prioritizing individual interests to the detriment of  collective interest.
2. rIght to heAlthcAre And evolutIon of judIcIAl decIsIons.
Defining what health is, and specifically the right to healthcare, its object and extent, is not an easy task. 
If  it is decided to depart from the concept contained in the 1946 Constitution of  the World Health Organi-
zation1, a difficulty further amplified. In fact, such a “state of  complete well-being” seems unreal. At most, 
there is an ideal to be achieved, but in practice it demands multiple stages and modalities of  action by public 
authorities and society. Such imprecision undoubtedly contributed to greater intervention by the Judiciary 
in the fulfillment of  its content, through the determination of  the delivery of  medicines.
The interpretation of  art. 196 of  the Constitution, therefore, should consider two aspects which are 
more objective2: one that considers health as the effect of  social and economic policies that avoid risks of  
aggravation (protection in a broad sense) and another that imposes the universal and equal access to actions 
and services that promote, protect and recover health. The first part requires the adoption by the State of  
public policies3 that guarantee the conditions for a quality life (education, sanitation, transportation, among 
other dimensions); the second part covers access to services and actions that recover the health already 
affected by some disease and protect it in a strict sense, since in a broad sense protection is obtained through 
the conditions that ensure quality of  life. One dimension is more preventive; the other, more curative.
Health protection and promotion translate, synthetically, the evolution of  the legal protection of  this 
legal asset from a phase in which one had health as an individual asset, involved in a doctor-patient rela-
tionship, to a phase in which one identifies in health a collective good. The public relevance of  health as an 
asset was soon affirmed by the adoption of  measures to combat epidemics, which had already arisen in the 
Roman Empire4, and which constitute the embryo of  the future sanitary administrative police, nowadays 
characterized as sanitary surveillance. Industrialization and the urbanization of  societies have created other 
risks and turned a new role for the State into a necessity, this time as a provider of  health services, initially 
1  “Health is a state of  complete physical, mental and social well-being, and it does not consist only in the absence of  disease or 
infirmity ”.
2  SANTOS, Lenir. Judicialização da saúde e a incompreensão do SUS. Judicialização da saúde no Brasil. Campinas: Saberes, 2014. p. 130.
3  NUNES, António José Avelãs; SCAFF, Fernando Facury. Os tribunais e o direito à saúde. Porto Alegre: Livraria do Advogado, 
2011. p. 79.
4  ESTORNINHO, Maria João; MACIEIRINHA, Tiago. Direito da saúde. Lisbon: Universidade Católica, 2014. p. 10.
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for workers who contributed to insurance or social security systems, or later, for the population as a whole, 
with the idea of  universality.
Health as an integral care, inheriting such evolution, presupposes a set of  services, goods and supplies 
that “have direct costs for the Unified Health System, with a network structure based in health regions, 
organized in levels of  services of  greater or lesser technological density built from primary health care”.5 
Such a network imposes a division of  competences and resources among the entities of  the Federation, 
according to the needs and the economic and demographic conditions of  each entity. The second part of  
the provision of  art. 196 of  the Constitution. That is, actions and services of  promotion, protection (in the 
strict sense) and recovery of  health. From the art. 6º of  8.080/09/1990, it can be affirmed that the scope of  
the Brazilian Unified Health System includes the so-called health surveillance (sanitary and epidemiological) 
and comprehensive therapeutic care, including pharmaceuticals. This does not neglect science and techno-
logy and the training of  personnel6. Assistance is organized in a network, with different levels of  complexity 
(primary, secondary and tertiary care).
This Unified Health System action is not exclusive, since art. 199 of  the Constitution allows the partici-
pation of  private initiative in the field of  public health, by means of  a contract or agreement (§1 of  article 
199), configuring complementary health, and also allowing the exploitation of  health services for profit 
purposes (caption of  article 199), being it, in this case, supplementary health. Even private (supplementary) 
health, however, has public relevance, in the form of  art. 197 of  the Constitution, and the State shall regu-
late, supervise and control it.
With respect to public health, which is the responsibility of  the State, its organization is drawn in prin-
ciple by art. 200 of  the Constitution and implemented by legal instruments, such as Law 8.080/09/1990 
and Complementary Law 141/01/2012. This last one, which deals with the minimum values to be applied 
annually, by the Federation, State, Federal District and Municipalities, with actions and health services, 
conceptuates, for financing purposes, such actions and services in its art. 3º. On the other hand, Decree 
7.508/06/2011 defines health care as a set of  services divided into increasing levels of  attention and com-
plexity, and also indicates the “entrance doors” in the Unified Health Systems, in the form of  art. 9th: pri-
mary care, emergency and urgency care, psychosocial care, and special forms of  open access.
In the form of  art. 6, item I, paragraph “d”, of  Law 8.080/09/1990, it is included in the Unified Health 
System field of  action the execution of  actions of  “comprehensive therapeutic care, including pharmaceu-
ticals”. This topic is where the judicialization is allowed with reference to the supply of  medicines.
Health judicialization means the determination by judicial decisions of  the provision of  a particular 
benefit, of  a particular treatment or medicine, by the public authorities and, in the case of  supplementary 
health, by private health plans and health insurance.
Specifically with regard to the Ministry of  Health’s spending on the acquisition of  medicines by virtue 
of  judicial decisions, that is, without considering the impact for States and Municipalities and for the Federal 
District, it has gone from R$139.6million in 2010 to R$838.4million in 20147. In 2015 the amount went to 
R$1.2 billion. By 2016, up to June, R$ 686.4 million had already been spent8. 
In the Brazilian case, the degree of  intervention of  the Judiciary leads to decisions that: a) do not, as a 
rule, consider the scientific efficacy of  treatments and drugs sought in court9; b) do not analyze the cost-
5  SANTOS, Lenir. Judicialização da saúde e a incompreensão do SUS. Judicialização da saúde no Brasil. Campinas: Saberes, 2014. p. 132.
6  SANTOS, Lenir. Judicialização da saúde e a incompreensão do SUS. Judicialização da saúde no Brasil. Campinas: Saberes, 2014. p. 137.
7  According to the Ministry of  Health as in a piece of  News. Available at: <http://portalsaude.saude.gov.br/index.php/ci-
dadao/principal/agencia-saude/20195-em-cinco-anos-mais-de-r-2-1-bilhoes-foram-gastos-com-acoes-judiciais>., Access on: 04 
Dec. 2016.
8  Rare diseases affect 13 million Brazilians. Available at: <http://noticias.uol.com.br/saude/ultimas-noticias/estado/2016/06/13/
doencas-raras-afetam-13-milhoes-de-brasileiros.htm>. Access on: 11 Nov. 2016.
9  DIAS, Eduardo Rocha; SILVA JÚNIOR, Geraldo Bezerra da. Evidence-based medicine in judicial decisions concerning right 
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-effectiveness of  the measures sought; c) result in purchases made without bidding, due to the urgency gene-
rated by the judicial determination, and entail excessive expenses for the treasury; d) subtract high volumes 
from the public budget; e) benefit people without considering criteria of  distributive justice, but only the 
success in having access to justice and obtaining favorable decisions, and f) disregard priorities and public 
policies drawn up by the bodies that are legitimized for this purpose10. 
The peculiarities of  the Brazilian public health system, which is based on a division of  competencies 
among the different federated entities, can also bring significant impacts to entities with smaller budgets, 
as is the case of  Municipalities, given the recognition, through precedents, that plaintiffs can bring actions 
against any federated entity or against all of  them, for being solidary11.
It is true that there has been a change in judicial decisions, especially if  considering the position of  
the Superior Court of  Justice and the Federal Supreme Court12. If, in the first instance, decisions tended 
to deny the granting of  medicines, there was an increase in favorable decisions initially linked to access to 
medicines for the treatment of  HIV infection. The reference to the constitutional character of  the right to 
healthcare and to the dignity of  the human person has become the basis for concessive decisions and for the 
attainment of  indices of  claims exceeding 80%13. The work of  the Judiciary, under the pretext of  effecting 
social rights, ends up transforming them into individual rights, disregarding the budget and the care of  the 
community14.
It is worth remembering the hypothesis, referred to by José Augusto Dias de Castro15, of  a decision 
based solely on journalistic news, determining the supply of  medicine which was still in the testing phase16. 
The Federal Supreme Court itself  came to recognize the right to treatment abroad for retinitis pigmentosa 
despite the lack of  scientific evidence of  the efficacy of  the therapy sought17.
From 2009, the beginning of  a trend alteration starts, motivated by factors of  two orders.
Through the initiative of  the Judiciary itself, the criteria for judicial intervention was discussed. It should 
to healthcare. Einstein, São Paulo, v. 14, n. 1, Jan./Mar. 2016. p. 4.
10  WANG, Daniel. Courts as healthcare policy-makers: the problem, the responses to the problem and the problem in the re-
sponses. São Paulo Law School of  Fundação Getúlio Vargas – Direito GV. Research Paper Series – Legal Studies. Paper n. 75, p. 3. 
In <http://bibliotecadigital.fgv.br/dspace/bitstream/handle/10438/11198/RPS_75_final.pdf?sequence=1>. Access on: 20 Apr. 
2014.
11  In accordance with the precedents of  the STF (SL 47 AgR, Tribunal Pleno, judged on 17-3-2010), of  the STJ (AgRg no REsp 
1136549/RS, judged on 8-6-2010) and the TNU (REQUEST 200481100052205, DOU 11-3-2011), the operation of  the Unified 
Health System (SUS) is joint liability of  the Union, the Member States and the Municipalities, so that any of  these entities have legiti-
macy ad causam to appear in the passive demand pole that guarantees the access to the medication for people deprived of  financial 
resources.  This is because there is no constitutional provision that determines that a federated entity only has the duty to provide 
medicines, to the exclusion of  others. Of  all sorts of  things, it can not be disregarded that the Constitution itself  provides that it is 
for the law to dispose of  the regulation and execution of  health services (article 197) and that the respective actions and services are 
part of  a regionalized, hierarchical and decentralized network (article 198 and its item I), which allows for the distribution of  tasks 
among federated entities, including the supply of  medicines.
12  BALESTRA NETO, Otávio. A jurisprudência dos tribunais superiores e o direito à saúde – evolução rumo à racionalidade. 
Direito Sanitário magazine, São Paulo, v. 16, n. 1, Mar./June 2015. p. 90-91.
13  WANG, Daniel. Courts as healthcare policy-makers: the problem, the responses to the problem and the problem in the responses. São Paulo 
Law School of  Fundação Getúlio Vargas – Direito GV. Research Paper Series – Legal Studies. Paper n. 75, p. 20-21. In <http://
bibliotecadigital.fgv.br/dspace/bitstream/handle/10438/11198/RPS_75_final.pdf?sequence=1>. Access on: 20 Apr. 2014.
14  SCAFF, Fernando Facury. A efetivação dos direitos sociais no Brasil. Garantias constitucionais de financiamento e judicialização. A Eficácia 
dos Direitos Sociais – I Jornada Internacional de Direito Constitucional Brasil/Espanha/Itália. São Paulo: Quartier Latin, 2010. p. 
29-30.
15  A questão do direito fundamental à saúde sob a ótica da análise econômica do direito. Direito Público da Economia magazine, year 
6, n. 21, p. 149-158, jan./mar. 2008. p. 155.
16  In this case, it was ENBREL, which cost four thousand reais a box. Ordinance of  the Ministry of  Health recommended the 
use of  another drug, Infliximab, whose effectiveness was best demonstrated. The case reached the Federal Supreme Court in Ex-
traordinary Appeal 271.286, which, however, did not take into account the technical aspects, but only recognized the duty of  the 
State to provide medicines to a person deprived of  remedies when linking the right to health with the right to life.
17  RE 368564/DF, Rapporteur Ministro Marco Aurélio, 1a Class, judged om 04/13/2011.
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be highlighted the public hearing held in the Federal Supreme Court between April and May 2009, in which 
specialists from a wide range of  areas were heard to obtain subsidies for the Court’s actions in actions invol-
ving access to benefits in the health area.
As a result of  the aforementioned public hearing, the National Council of  Justice (CNJ) issued Recom-
mendation 31 of  March 30, 2010, urging State Courts of  Justice and Federal Regional Courts to conclude 
agreements aimed at providing technical support from doctors and pharmacists to assist magistrates in 
the formation of  a value judgment regarding the assessment of  the clinical issues presented by the health 
action parties, observing the regional peculiarities. The courts were also requested, through their respective 
inspecting agencies, to direct the magistrates, among other measures, to seek to instruct the actions in which 
they act, as far as possible, with medical reports, with a description of  the disease, including ICD, containing 
prescription of  medicines, with generic name or active principle, products, orthoses, prostheses and supplies 
in general, with exact dosage, avoid authorizing the supply of  medicines not yet registered by ANVISA, or 
in an experimental phase, excepting the ones expressly provided by law, listening, when possible, preferably 
by electronic means, the public managers, before the assessment of  emergency measures.
It is curious to notice that many of  such recommendations go as far as to urge judges to comply with 
the law, using prudence, dialogue between the parties involved, rationality, when determining the supply of  
a drug for example.
It is worth mentioning among the measures adopted by the CNJ that the National Forum of  the Judicia-
ry was set up to monitor and resolve demands for health care- the Health Forum, through Resolution 107 of  
April 6, 2010. The said Forum subsequently extended its area of  operation to include supplementary health 
and legal actions involving consumer relations. Then, Recommendation 36, dated July 12, 2011, was issued 
specifically for the lawsuits involving supplementary health.
In the latter, it is also recommended that the Courts of  Justice and the Federal Regional Courts conclude 
agreements aimed at providing technical support without burden to the Courts, composed of  doctors and 
pharmacists, to assist magistrates “in forming a judgment on the value of  assessment of  the clinical issues 
presented by the parties “.
Secondly, in addition to the work of  the Judiciary, it is worth recording the edition of  Law 12.401/04/2011, 
which established criteria for the incorporation of  new health technologies by the Unified Health System 
and clearer competences in this regard. It is to be hoped that such diploma will serve to instil greater defe-
rence from the Judiciary to administrative decisions, to help overcome the prevailing conception that the 
Judiciary may ignore the public policies drawn up by the legitimized bodies18.
3. the ActIons of the legIslAtIve And current trends In judIcIAl decIsIons
Law 12.401/04/2011 inserted Chapter VIII in Title II of  Law 8.080/1990, which refers to the condi-
tions for promotion, protection and recovery of  health and the organization and functioning of  the corres-
ponding services. According to article 19-Q of  the law, the attributions to incorporate, exclude or change 
new drugs by the Unified Health System were disciplined as follows:
Art. 19-Q. The incorporation, exclusion or modification by the Unified Health System of  new 
medicines, products and procedures, as well as the constitution or modification of  a clinical protocol or 
therapeutic guideline, are attributed by the Ministry of  Health, assisted by the National Commission for 
18  WANG, Daniel. Courts as healthcare policy-makers: the problem, the responses to the problem and the problem in the 
responses. São Paulo Law School of  Fundação Getúlio Vargas – Direito GV. Research Paper Series – Legal Studies. Paper n. 75, 
p. 49-50. Available at:  <http://bibliotecadigital.fgv.br/dspace/bitstream/handle/10438/11198/RPS_75_final.pdf?sequence=1>. 
Access on: 20 Apr. 2014.
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the Incorporation of  Technologies in the Unified Health System.
The National Commission for the Incorporation of  Technologies to the Unified Health System (CONI-
TEC) is responsible for preparing a report and deciding on the basis of  “scientific evidence on the efficacy, 
accuracy, effectiveness and safety of  the drug, product or procedure subject to the process, accepted by the 
body responsible for registration or authorization of  use “(item I of  § 2 of  article 19-Q of  Law 8.080/1990). 
The Commission will also take into account the “comparative economic evaluation of  benefits and costs in 
relation to technologies already incorporated, including in regard to home, outpatient or hospital care, when 
appropriate” (item II of  § 2 of  article 19- Q of  Law 8.080/09/1990).
The arts. 19-M, 19-N and 19-O, added by Law 12.401/04/2011, deal with the dispensation of  drugs and 
products of  health interest, which must observe therapeutic guidelines defined in clinical protocol for the 
disease or injury to be treated. By clinical protocol and therapeutic guideline it is understood, as foreseen in 
item II of  art. 19-N of  Law 8.080/1990, the:
document which establishes criteria for the diagnosis of  the disease or health problem; the recommended 
treatment, with medicines and other appropriate products, when appropriate; the recommended 
dosages; the mechanisms of  clinical control; and the monitoring and verification of  therapeutic results, 
to be followed by SUS managers.
As provided in art. 19-O of  Law 8.080/1990, clinical protocols and therapeutic guidelines should:
establish the medicines or products necessary in the different evolutionary stages of  the disease or of  
the health problem they treat, as well as those indicated in cases of  loss of  efficacy and the appearance 
of  intolerance or relevant adverse reaction caused by the first product, product or procedure choice.
The sole paragraph of  art. 19-O of  Law 8.080/1990 establishes that “if  needed, the medicines or pro-
ducts will be evaluated for their efficacy, safety, effectiveness and cost-effectiveness for the different evolu-
tionary stages of  the disease or the health protocol”.
In the absence of  a clinical protocol or therapeutic guideline, dispensation will be performed, as provi-
ded in art. 19-P of  Law 8.080/2011:
 I - based on the relations of  medicines instituted by the federal manager of  the Unified Health System, 
observing the competencies established in Law 8.080/1990, and the responsibility for the supply will be 
agreed in the Tripartite Interagency Committee; 
II - within the scope of  each State and the Federal District, in a supplementary manner, based on 
the relations of  medicines instituted by the state managers of  the Unified Health System, and the 
responsibility for the supply will be agreed in the Bipartite Interagency Committee;
III - in the scope of  each Municipality, on an additional basis, based on the relations of  medicines 
instituted by the municipal managers of  Unified Health Sytem, and the responsibility for the supply will 
be agreed in the Municipal Health Council.
The provisions of  the Code of  Civil Proceedings of  2015 (Law 13.105/2015) and of  Law 13.140/2015 
seems to be of  no minor importance, regarding the search for a consensual solution of  conflicts, including 
in the scope of  the public administration. It opens up a vast field to try to arrive at dialogued and consensual 
solutions, in which the administration can show the Judiciary its role and the alternatives available in the 
field of  public health. It also allows the improvement of  the state performance, informing the services and 
actions made available and allowing the citizen’s service.
As Lenir Santos reminds us19, the responsibilities of  each member of  the Brazilian Federation in terms 
of  the provision of  health services are due to the complexity of  such services and the compatibility with 
socioeconomic, demographic and geographical levels. They must, together with society, set guidelines that 
guide the choices of  therapies, since “there isn’t money for everything”. The Unified Health System can not 
19  JUDICIALIZAÇÃO da saúde e a incompreensão do SUS. Judicialização da saúde no Brasil. Campinas: Saberes, 2014. p. 138.
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be “a concession desk for procedures that are detached from guidelines essential to its systemic organization 
and sanitary security”20. Hence the role of  the National Agency of  Sanitary Surveillance - ANVISA, acting 
in the field of  efficacy and safety of  medicines, products and procedures, and the National Commission 
for the Incorporation of  Technologies in Health - CONITEC, which should evaluate which drugs will be 
incorporated, as seen above, based on evidence-based criteria on efficacy, accuracy and safety, as well as the 
costs and benefits of  the available alternatives.
It should be emphasized that the Unified Health System guarantees to the population, in what concerns 
health care, procedures and services contained in RENASES - List of  Health Actions and Services and 
RENAME – National List of  Essential Medicines, disciplined by arts. 21 to 29 of  Decree 7.508/06/2011.
A decision of  the Supreme Federal Court, in which the role of  ANVISA was recognized, is the one pro-
nounced in the case of  synthetic phosphoethanolamine, known as the “cancer pill”. This is ADI 5501, whereby 
the Brazilian Medical Association (AMB) questioned Law 13.269/04/2016, which authorized the dispensing 
of  said substance without its efficacy and safety being certified by the entity authorized to do so, in the case the 
ANVISA. By a majority, the Supreme Federal Court understood that the legislative action violated the separation 
of  powers, besides opening a dangerous precedent to the health protection of  the population. The Rapporteur, 
Luís Roberto Barroso, alluded to the existence in the species of  an “administrative reserve” and that the techni-
cal judgment of  ANVISA was improperly replaced by a political judgment of  the parliament.
In 2017, the Supreme Court of  Justice, in deciding Special Appeal 1,663,141/SP, filed by a health plan 
operator in response to the decision that ordered the supply of  imported medicine without registration with 
ANVISA, reversed prior ruling, deciding that there was a violation of  both the Law 9,656/06/1998, whose 
art. 10, item V, makes it possible for health plans to exclude from their coverage the supply of  imported 
non-nationalized drugs, as well as art. 12 of  Law 6,360/1976, which establishes the need to register with the 
competent body of  imported medicines. The decision is important because it may also reflect a change of  
understanding regarding the supply of  medicines not registered in public health21, imposing law enforce-
ment and greater deference to ANVISA’s actions.
Another important decision, issued in the judgment of  Extraordinary Appeal 566471 and 657718, is re-
lated to the supply of  high-cost medicines not registered in ANVISA nor made available by Unified Health 
System for the treatment or control of  rare diseases. According to the World Health Organization (WHO), 
rare diseases are those that affect up to sixty-five per 100,000 people22. In Europe and the United States, 
studies indicate that between 6% and 8% of  the population is affected by some rare disease. There are no 
comprehensive studies in Brazil23. In a population like the Brazilian one, this implies considering a universe 
of  between thirteen and fifteen million people.
The trial was suspended on September 28, 2016 after three votes were issued. Initially, Minister Marco Au-
rélio proposed the following thesis at the trial: “recognition of  the individual right to the provision by the State 
of  a high-cost drug not included in a National Drug Policy or an Exceptional Dispensing Drug Program, in ex-
ceptional character, a constant list of  the approved ones, depends on the demonstration of  the indispensability 
- adequacy and necessity -, the impossibility of  replacing the drug and the financial incapacity of  the patient, and 
the lack of  spontaneity to help from the members of  the family in solidarity, respected the dispositions about 
alimony of  articles 1,694 to 1,710 of  the Civil Code, and the right of  recourse is guaranteed24”.
20  JUDICIALIZAÇÃO da saúde e a incompreensão do SUS. Judicialização da saúde no Brasil. Campinas: Saberes, 2014. p. 139.
21  SCHULZE, Clenio Jair. STJ inaugura nova posição na judicialização da saúde. Available at: <http://emporiododireito.com.br/stj-
inaugura-nova-posicao-na-judicializacao-da-saude-por-clenio-jair-schulze/>. Access on: 4 Sept. 2017.
22  Ministry of  Health launches clinical protocols for 12 rare diseases, Available at: <http://portalsaude.saude.gov.br/index.
php/cidadao/principal/agencia-saude/18086-ministerio-da-saude-lanca-protocolos-clinicos-para-12-doencas-raras>. Access on: 
11 Nov. 2016.
23  Information available at: <http://rederaras.org>. Access on: 11 Nov. 2016.
24  REQUEST for examination of  case dockets postponed trial on access to high cost drugs by judicial process” Available at: 
<http://www.stf.jus.br/portal/cms/verNoticiaDetalhe.asp?idConteudo=326275> Access on: 11 Nov. 2016.
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Subsequently, Minister Luís Roberto Barroso, after stating that the discussion of  the subject should be sub-
tracted from the Judiciary, which is not responsible for defining public health policies, but only intervening in ex-
treme situations,  affirmed that, as a rule, in case of  unincorporated drugs, including high cost, the State can not be 
obliged to provide them. “There is no health system that can withstand a model in which all medicines, regardless 
of  their cost and financial impact, must be offered by the State to all people,” he added25. After, he proposed five 
cumulative criteria that must be observed by the Judiciary so that certain health benefits can be inferred:
Financial inability to bear the corresponding cost; demonstration that the non-incorporation of  the drug 
did not result from an express decision of  the competent organs; inexistence of  therapeutic substitute 
incorporated by the Unified Health System; evidence of  efficacy of  the medicinal product sought in the 
light of  evidence-based medicine; since the responsibility for the final decision on the incorporation or 
non-incorporation of  medicines is exclusive of  this federative entity26. 
It must outlined that one unexpected consequence of  excluding the rich from assistance is undermining 
the principle that Unified Health System should be universal. Although Constitution has that it is possible 
for the Legislative to be selective upon granting protection within the scope of  social security rights, as can 
be seen in number 3 of  the sole paragraph of  article 194, denying access to category of  persons may open 
the door to future exclusions of  other categories thus affecting Unified Health System claim to universality.
Minister Luís Roberto Barroso also defended a dialogue between the Judiciary and people and organs 
endowed with knowledge in the area of  health, either to verify, initially, the presence of  the requirements for 
dispensing the drug, or, once determined its supply in the judicial process, in order to evaluate the possibility 
of  its incorporation. Regarding medicines not registered with ANVISA, he proposed the following thesis 
with general repercussions:
The State can not be required to supply experimental medicines without proven efficacy and safety under 
any circumstances.  Regarding medicines not registered with Anvisa, but with proof  of  efficacy and 
safety, the State can only be obliged to provide them in the event of  unreasonable delay of  the agency in 
assessing the application for registration (term longer than 365 days), when three requirements are met: 
1) the existence of  an application for registration of  the drug in Brazil; 2) the existence of  registration 
of  the drug in renowned regulatory agencies abroad; and 3) the inexistence of  a therapeutic substitute 
with registration in Brazil. The actions that demand the supply of  medicines without registration in 
Anvisa must necessarily be proposed to the Union27.  
Finally, Minister Edson Fachin considered that there is a subjective right to public health care policies, 
and there is a violation of  individual rights due to failure, omission or delay in the provision, then suggesting 
that it is preferable to take collective actions, not individual ones, in the fulfillment of  the right to healthcare, 
and that the management of  individual actions should be exceptional, in addition to requiring a large pro-
bative output regarding the inefficacy of  the existing public policy, also proposing criteria for the Judiciary 
to impose the provision or costing of  medicines or health treatments:
1) necessary to demonstrate prior administrative application to the public network; 2) preferential 
prescription by a physician connected to the public network; 3) preferred designation of  the drug by 
the Common Brazilian Denomination (DCB) and, in the absence of  the DCB, the IND (International 
Common Denomination); 4) justification of  the inadequacy or lack of  medication/treatment dispensed 
in the public network; 5), and in case of  refusal of  dispensing in the public network, it is necessary to 
carry out a medical report indicating the necessity of  the treatment, its effects, studies of  evidence-
based medicine and advantages for the patient, and compare with eventual drugs provided by the 
Unified Health System”28. 
25  REQUEST for examination of  case dockets postponed trial on access to high cost drugs by judicial process” Available at: 
<http://www.stf.jus.br/portal/cms/verNoticiaDetalhe.asp?idConteudo=326275>. Access on: 11 Nov. 2016.
26  REQUEST for examination of  case dockets postponed trial on access to high cost drugs by judicial process” Available at: 
<http://www.stf.jus.br/portal/cms/verNoticiaDetalhe.asp?idConteudo=326275>. Acesso em: 11 Nov. 2016.
27  REQUEST for examination of  case dockets postponed trial on access to high cost drugs by judicial process” Available at: 
<http://www.stf.jus.br/portal/cms/verNoticiaDetalhe.asp?idConteudo=326275>. Acesso em: 11 Nov. 2016. 
28  REQUEST for examination of  case dockets postponed trial on access to high cost drugs by judicial process” Available at: 
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The Minister also stressed that the Judiciary should take a more deferential stance regarding the technical 
and democratic choices of  the competent bodies, which must also be accountable for their actions and be 
transparent regarding the criteria adopted.
A concern with the respect for public policies and the criteria established by law and Administration for 
the registration and incorporation of  new technologies has been expressed in the votes of  the Ministers 
which have pronounced themselves until now, especially in the vote of  Minister Luís Roberto Barroso. The-
re is still a possibility of  judicial intervention and the proposed criteria may actually lead to a replication, in 
the judicial sphere, of  procedures that should be adopted in the administrative sphere, which is not reaso-
nable, except in exceptional cases. The Judiciary does not have the structure, the expertise, does not involve 
the participation of  all those interested in the public policy in question and does not appreciate problems of  
equity regarding the access to budget funds29.
It is interesting to observe that the discussion undertaken here approaches the identification of  limits 
to the institutional capacities of  the Judiciary. Cass Sunstein and Adrian Vermeule30 argue that the issue of  
interpretation in law, in particular the greater or lesser deference to the textual meanings of  legal norms, 
must take into account institutional aspects. Among these aspects, they point out the reliability of  the judges, 
especially if  they have specific knowledge regarding the legislation they intend to apply, and the systemic 
effects that their decisions may entail. That is, can generalist judges adopt broader interpretations of  texts 
on unknown specific subjects, such as those related to health, for example? Or is it better to adopt narrower, 
more formal interpretations? Can judges assess the consequences of  their decisions on the health system 
and the budget? The paths indicated by the votes given above point to a possible reversal in the tendency to 
grant everything in the field of  health judicialization from institutional elements as well.
It is commendable, on the other hand, the concern about a transparency of  administrative procedures 
for registering and incorporating new drugs.  This may lead to a type of  judicial intervention, of  a collective 
nature and no longer individual, that questions the public policy itself  and includes the possibility of  deman-
ding the presentation of  the criteria for the decision, which eventually determines that the matter is reviewed 
in the administrative level and which is concerned with equity in the distribution of  public resources and 
with the scientific effectiveness of  medicines and treatments.
Brazilian legislation, as in Law 12.401/04/2011, may fulfill in this field a pedagogical role, of  reminding 
judges that they can not do everything and that there are technical aspects to be considered and that their 
decisions inevitably hide. A reserve of  administration or greater deference to legislative and administrative 
decisions is thus affirmed, which can only be dismissed by the Judiciary in exceptional situations. The so-
-called Chevron doctrine, elaborated by the US Supreme Court, can still be invoked in this sense.
The concrete case which led to the affirmation of  the Chevron doctrine involved the questioning of  the 
legality of  norms issued by the environmental protection agency of  that country31. According to this doc-
trine, the Judiciary must maintain the interpretation of  a law made by the agencies, by means of  regulations, 
for example, unless such interpretation is inconsistent with clearly expressed parliamentary intent. For this 
reason, the Chevron doctrine implies respect or judicial deference to administrative interpretations (judicial 
deference), about which it is important to define not whether they are correct, but whether they are admis-
<http://www.stf.jus.br/portal/cms/verNoticiaDetalhe.asp?idConteudo=326275>. Acesso em: 11 Nov. 2016.
29  WANG, Daniel. Courts as healthcare policy-makers: the problem, the responses to the problem and the problem in the re-
sponses. São Paulo Law School of  Fundação Getúlio Vargas – Direito GV. Research Paper Series – Legal Studies. Paper n. 75, p. 50. 
Request for examination of  case dockets postponed trial on access to high cost drugs by judicial process” Available at:   <http://
www.stf.jus.br/portal/cms/verNoticiaDetalhe.asp?idConteudo=326275>. Acesso em: 11 Nov. 2016. <http://bibliotecadigital.fgv.
br/dspace/bitstream/handle/10438/11198/RPS_75_final.pdf?sequence=1>. Access on: 20 Apr. 2014.
30  SUNSTEIN, Cass; VERMEULE, Adrian. Interpretation and institutions. University of  Chicago Law School. Coase-Sandor Work-
ing Paper Series in Law and Economics, 2002, p. 48. Available at: < <http://chicagounbound.uchicago.edu/cgi/viewcontent.
cgi?article=1279&context=law_and_economics>. Access on: 4 Sept. 2017.
31  SCHWARTZ, Bernard. Administrative law. Boston: Little, Brown and Company, 1991. p. 701-702.
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sible. That is, the Judiciary should not replace the interpretation adopted by the agency, unless it violates the 
law clearly. If  it does not violate it, administrative interpretation must prevail.
Above all, it seems necessary to establish an institutional dialogue and affirmation of  the powers of  
public officials, since sometimes not even the health professionals themselves seem to know the clinical 
protocols and the procedures they envisage, not demonstrating sensitivity to the aspect of  cost and the 
effectiveness of  treatments and impacts for the budget and society.
Such dialogue could take place in a consensual solution of  litigation, such as mediation, transaction and 
other forms of  amicable dispute settlement, encouraged by the 2015 Code of  Civil Proceedings and Law 
13.140/06/2015. Also through technical conciliation nuclei, which allow the intermediation between health 
plans or the Unified Health System and the Judiciary, already adopted in some Brazilian courts.
This bias reveals a mechanism whose study and application may prove interesting, for this purpose:  the 
so-called meaningful engagement, developed by the Constitutional Court of  South Africa32. It is a case law 
construction that seems to serve to respect the separation of  powers and at the same time ensure the reali-
zation of  fundamental rights that require allocation of  resources from the budget. In the Olivia Road case 
of  2008, which resulted from a building eviction order issued by the city of  Johannesburg to the detriment 
of  more than 400 people for health and safety reasons, the Court determined that the city and the occupants 
should make a significant commitment to resolve the conflict in the light of  the values  of  the Constitution, 
to guarantee living conditions for those living in the buildings, ensure health and safety, and report back to 
the Court later on the results of  the compromise.
The main advantage in adopting such a commitment is the overcoming of  a unilateral imposition by the 
Judiciary, which affects the budget, through a consensual and participatory solution, under the supervision 
of  the Judiciary, with greater respect for the separation of  powers33. There is already a Brazilian Senate bill 
(PLS 736, 2015) that seeks to include a significant commitment to the country’s constitutional control sys-
tem34.
4. conclusIon
The analysis of  the evolution of  judicial decisions related to the topic of  health judicialization shows an 
interesting dynamic. From a phase of  self-restraint, a maximization of  the Judiciary’s action followed, in the 
context of  the Brazilian Constitution of  1988 and the affirmation of  new rights and promises that it had 
set up.
However, the excesses of  this phase were noticed, due to the lack of  consideration, among other aspects, 
of  legal forecasts, limits of  budgets and the consequences for the public health system of  judicial interven-
tion. Not to mention problems of  equity in the care and distribution of  public resources.
The fundamental right to healthcare, based on the general prediction of  art. 196 of  the Constitution 
and the consideration of  human dignity, can not lead to granting extremely expensive or untested drugs 
and unproven results to all applicants, without considering the competence established by the Legislative 
32  VIEIRA JUNIOR, Ronaldo Jorge Araújo. Separação de poderes, estado de coisas inconstitucional e compromisso signifi-
cativo: novas balizas à atuação do Supremo Tribunal Federal. Senado Federal: Brasília, 2015, p. 29. Available at: <https://www12.
senado.leg.br/publicacoes/estudos-legislativos/tipos-de-estudos/textos-para-discussao/td186>. Access on: 18 Dez. 2016. 
33  VIEIRA JUNIOR, Ronaldo Jorge Araújo. Separação de poderes, estado de coisas inconstitucional e compromisso signifi-
cativo: novas balizas à atuação do Supremo Tribunal Federal. Senado Federal: Brasília, 2015, p. 50. Available at: <https://www12.
senado.leg.br/publicacoes/estudos-legislativos/tipos-de-estudos/textos-para-discussao/td186.>. Access on: 18 Dez. 2016.
34  VIEIRA JUNIOR, Ronaldo Jorge Araújo. Separação de poderes, estado de coisas inconstitucional e compromisso signifi-
cativo: novas balizas à atuação do Supremo Tribunal Federal. Senado Federal: Brasília, 2015, p. 34. Available at: <https://www12.
senado.leg.br/publicacoes/estudos-legislativos/tipos-de-estudos/textos-para-discussao/td186>. Access on: 18 Dez. 2016.
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for technical instances, the cost of  incorporation of  new drugs and the scientific evidence regarding its 
effectiveness.
The problems caused by the excesses of  the judicial intervention were faced by the Judiciary itself, and 
also by the Legislative, as highlighted in this work. It can even be said that the edition of  Law 12.401/04/2011 
has fulfilled the scope of  reaffirming the technical competencies of  the Executive, for example, regarding 
the incorporation of  new technologies in health and the definition of  clinical protocols. The legislator, 
therefore, may play an important role in reaffirming the Executive’s technical competencies, and in a peda-
gogical way, set limits for judicial intervention.
The pendulum must return to the position of  greater balance between individual interests and rights and 
collective needs, and it is necessary to consider the greater institutional expertise of  the entities to whom the 
legislation gives competence, for example, to decide on the effectiveness and safety of  new drugs, as is the 
case in Brazil, of  ANVISA, as well as from the bodies that design and implement public health policies and 
the incorporation of  new technologies.
It is reaffirmed that the judicialization may take a new course, no longer purely individual, but to con-
sider the way in which these policies are exercised and the actions of  the institutions which have to decide. 
In this sense, it is essential to have a permanent dialogue between the Judiciary and these bodies, in order 
to clarify the limits of  their institutional capacities and to find consensual solutions, to remove obstacles, 
incomprehensions and mutual distrust. Dialogue, mediation, partnership and advice from scientists and te-
chnicians seem to be a timely way forward, with a view to realizing the right to healthcare without affecting 
budgets and the implementation of  public policies in this area.
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